COMMUNIQUÉS West-GlobeNewswire

MyoGen : Les leaders d’une révolution anabolique
25/05/2018
GUJARAT, Inde, 25 mai 2018 (GLOBE NEWSWIRE) -- Myogen vous fera repenser les limites du corps humain Être un athlète signifie participer à une quête sans fin d’autoamélioration. Une obsession à la recherche d’un [...]
Bardoxolone Methyl Improved Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease and IgA Nephropathy in the Ongoing Phase 2 Phoenix Study
25/05/2018
Interim Data Demonstrate Significant Improvement in Kidney Function in Both Diseases Conference Call With Management Scheduled Today, May 25, 2018 at 8:00am ET IRVING, Texas, May 25, 2018 (GLOBE NEWSWIRE) -- Reata [...]
NeuroSearch A/S: Publication of offer document
25/05/2018
Company Announcement 25 May 2018 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH [...]
Vistin Pharma ASA : Last day of the subscription period in the subsequent repair issue
25/05/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]
ThromboGenics Enrolls First Patient in Phase 1 Clinical Study Evaluating THR-149, a plasma kallikrein inhibitor, for treatment of Diabetic Macular Edema (DME)
25/05/2018
Press release Leuven, Belgium, 25 May 2018 - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel medicines for diabetic eye disease, announces that it has successfully enrolled the first [...]
Extendicare Announces Voting Results from the 2018 Annual and Special Meeting of Shareholders and Board Change
25/05/2018
MARKHAM, Ontario, May 24, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) today announced the results of matters voted on at its annual and special shareholders’ meeting held on [...]
Burcon Announces Intention to File Form 25
24/05/2018
VANCOUVER, British Columbia, May 24, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (“Burcon” or the “Company”), a leader in natural product extraction, purification and isolation [...]
Hydropothecary Announces Acceleration of Warrant Expiry Date
24/05/2018
GATINEAU, Quebec, May 24, 2018 (GLOBE NEWSWIRE) -- The Hydropothecary Corporation (“THCX” or the “Company”) (TSX-V: THCX ) announced today that it has elected to exercise its right under the warrant indenture (the “ [...]
Hydropothecary annonce le devancement de l'échéance de bons de souscription
24/05/2018
GATINEAU, Québec, 24 mai 2018 (GLOBE NEWSWIRE) -- La société Hydropothecary (" THCX " ou la " Société ") (TSX CROISSANCE:THCX) a annoncé aujourd'hui qu'elle a choisi d'exercer son droit en vertu de l'acte de fiducie (l [...]
Amarin Announces Patent Litigation Settlement Agreement with Teva
24/05/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, May 24, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Retrophin to Present at Upcoming Investor Conferences
24/05/2018
SAN DIEGO, May 24, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX ) today announced that the Company’s management team will present at the following upcoming investor conferences in June: Jefferies 2018 Global [...]
Kane Biotech to Present at TakeStock! Investor Forum
24/05/2018
Forum Held May 31 in Association with TSX Venture Exchange WINNIPEG, Manitoba, May 24, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce [...]
ContraVir Pharmaceuticals, Inc. Announces Reverse Stock Split
24/05/2018
EDISON, N.J., May 24, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of therapeutic drugs for the treatment of [...]
Ogilvy CommonHealth Worldwide’s Johanna Skilling and Jennifer Werther to be honored at MM&M’s 2018 Hall of Femme ceremony
24/05/2018
PARSIPPANY, N.J., May 24, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide ( www.ogilvychww.com ), a WPP Health & Wellness company (NYSE: WPP ) ( www.wpp.com ), today announced Johanna Skilling, head of [...]
I-MED Pharma to Bring Clinically Proven E>Eye IRPL® Technology to Canada
24/05/2018
MONTREAL, May 24, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of a Canadian distribution agreement with ESW Vision [...]
I-MED Pharma présente la technologie éprouvée E>Eye IRPL® au Canada
24/05/2018
MONTRÉAL, 24 mai 2018 (GLOBE NEWSWIRE) -- I-MED Pharma inc., une entreprise canadienne spécialisée dans le diagnostic et la prise en charge de la sécheresse oculaire, est ravie d’annoncer l’officialisation d’une entente [...]
Announcement from Xbrane Biopharma's annual general meeting
24/05/2018
Press release 2018-05-24 The annual general meeting (" AGM ") of Xbrane Biopharma AB (" Xbrane " or the " Company ") was held today on 24 May 2018 and the following resolutions were passed by the meeting. Adoption of [...]
BioCryst's BCX7353 Receives European Regulatory Designations for the Treatment of Hereditary Angioedema
24/05/2018
EMA Grants Orphan Designation UK MHRA Grants Promising Innovative Medicine Designation RESEARCH TRIANGLE PARK, N.C., May 24, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ), a pharmaceutical [...]
BIOPHYTIS: Inclusion of the First Patient in Phase 2b Study in Sarcopenia
24/05/2018
Preliminary results expected in Q3 2019 PARIS, May 24, 2018 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris: ALBPS), a biotechnology company specializing in the development of drug candidates to fight age-related [...]

Pages